New Risk • Jun 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩66.5b market cap, or US$44.1m). Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩10,910, the stock trades at a trailing P/E ratio of 30.7x. Average trailing P/E is 17x in the Pharmaceuticals industry in South Korea. Announcement • Mar 04
Samik Pharmaceutical Company LTD., Annual General Meeting, Mar 31, 2026 Samik Pharmaceutical Company LTD., Annual General Meeting, Mar 31, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 11, beobwon-ro 11-gil, songpa-gu, seoul South Korea